Abstract:This review emphatically focusses on a comprehensive summary of the molecular design strategies of advanced organic semiconducting agents emitting in the second near‐infrared window (NIR‐II) for improving the properties of NIR‐II photonics and optimizing disease phototheranostics. By summarizing the current research progress, this review may shed light on organic semiconducting nanoplatforms for improving precise theranostics, while providing continuous breakthrough toward clinical transformation. Second near‐infrared window (NIR‐II, 1000−1700 nm) fluorescence imaging (FI) in phototheranostics benefits from deep tissue penetration, negligible body spontaneous fluorescence, exceptional spatiotemporal resolution, and diversified imaging agents. Inorganic and metal nanomaterials with NIR‐II emission are widely explored for NIR‐II FI, however, the concern about their intrinsic long‐term toxicity hampers further clinic applications. By contrast, whole organic NIR‐II FI agents, in particular, organic semiconducting molecules derived from large π‐conjugated molecular architectures and biologically amicable ingredients, owning inert photophysical potencies, tunable optical properties, and favorable biocompatibility, have the potential to be degraded and excreted from the body in molecular level. In this review, the development of NIR‐II fluorescence‐emitting organic semiconducting nanoplatforms, with a focus on their theranostic applications in biomedicine is discussed. The recent advances in the molecular design of semiconducting NIR‐II emitting agents for improving the properties of NIR‐II photonics (e.g., emission intensity, quantum yield, emission wavelength, and activatable emission) and optimizing disease phototheranostics (the synergistic combination of NIR‐II FI‐based diagnosis and photo‐related therapeutic methods) are highlighted. Finally, the challenges and perspectives to building high‐powered new‐generation organic semiconducting nanoplatforms for NIR‐II phototheranostics of a variety of diseases are discussed.

A Selenium-Based NIR-II Photosensitizer for a High Effective and Safe Phototherapy Plan

An NIR-II-emitting type-I photosensitizer for efficient hypoxic tumor phototheranostics

A simple therapeutic nanoplatform in the second near-infrared window for synergistic phototherapy

Rational Design of a High-Performance Quinoxalinone-Based AIE Photosensitizer for Image-Guided Photodynamic Therapy.

Polycyclic naphthalenediimide-based nanoparticles for NIR-II fluorescence imaging guided phototherapy

Zwitterionic AIEgens: Rational Molecular Design for NIR‐II Fluorescence Imaging‐Guided Synergistic Phototherapy

Remarkable Suppression of Vibrational Relaxation in Organic Semiconducting Polymers by Introducing a Weak Electron Donor for Improved NIR‐II Phototheranostics

Highly Stable Near-Infrared II Luminescent Diradicaloids for Cancer Phototheranostics

Tumor‐Targeting Near‐Infrared Dimeric Heptamethine Cyanine Photosensitizers with an Aromatic Diphenol Linker for Imaging‐Guided Cancer Phototherapy

Fused Azulenyl Squaraine Derivatives Improve Phototheranostics in the Second Near‐Infrared Window by Concentrating Excited State Energy on Non‐Radiative Decay Pathways

Rational Molecular Engineering of Organic Semiconducting Nanoplatforms for Advancing NIR‐II Fluorescence Theranostics

Dual-modal Imaging-Guided Agent Based on NIR-II Aggregation-Induced Emission Luminogens with Balanced Phototheranostic Performance

Concentrating Excited State Energy on Non‐Radiative Decay Pathways with Fused Azulenyl Squaraine Derivatives for Improving Second Near‐Infrared Phototheranostics

A novel water-soluble phthalocyanine-based organic molecule for the effective NIR triggered dual phototherapy of cancer

Molecular Engineering of Near‐Infrared‐II Photosensitizers with Steric‐Hindrance Effect for Image‐Guided Cancer Photodynamic Therapy

Rational Design of Near-Infrared-Absorbing Pt(II)-Chelated Azadipyrromethene Dyes as a New Generation of Photosensitizers for Synergistic Phototherapy

Achieving Efficient NIR‐II Type‐I Photosensitizers for Photodynamic/Photothermal Therapy upon Regulating Chalcogen Elements

Beyond traditional light: NIR-II light-activated photosensitizers for cancer therapy

A NIR-I Light-Responsive Superoxide Radical Generator with Cancer Cell Membrane Targeting Ability for Enhanced Imaging-Guided Photodynamic Therapy.

Highly Photostable Deep-NIR Chromophore with a Superior Molar Absorptivity for Efficient Photothermal Therapy

Organic Semiconducting Nanomaterials‐assisted Phototheranostics in Near‐infrared‐ii Biological Window